Evidence map›Paper›PMID 39193432›Full record

ArticleFrontiers in microbiology2024

Antimicrobial resistance patterns in

Marte Glambek, Steinar Skrede, Audun Sivertsen, Bård Reiakvam Kittang, Alba Kaci, Christine Monceyron Jonassen, Hannah Joan Jørgensen, Norwegian Study Group on Streptococcus dysgalactiae, Oddvar Oppegaard

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Emerging trends in invasiveEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. The dynamic Alp landscape ofFrontiers in cellular and infection microbiology · 2026
    Article
  3. Microorganisms · 2025
    Article
  4. Article
  5. Frontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marte GlambekDepartment of Medicine, Haukeland University Hospital, Bergen, Norway.
Steinar SkredeDepartment of Medicine, Haukeland University Hospital, Bergen, Norway.
Audun SivertsenDepartment of Microbiology, Haukeland University Hospital, Bergen, Norway.
Bård Reiakvam KittangDepartment of Clinical Medicine 2, Department of Clinical Science, University of Bergen, Bergen, Norway.
Alba KaciCenter for Laboratory Medicine, Østfold Hospital, Grålum, Norway.
Christine Monceyron JonassenCenter for Laboratory Medicine, Østfold Hospital, Grålum, Norway.
Hannah Joan JørgensenNorwegian Veterinary Institute, Ås, Norway.
Norwegian Study Group on Streptococcus dysgalactiae
Oddvar OppegaardDepartment of Medicine, Haukeland University Hospital, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We compared whole genome sequences and phenotypical antimicrobial susceptibility of 407 SD isolates, comprising all isolates obtained from human bloodstream infections in 2018 ( Results: Antimicrobial resistance genes were detected in 70 (26%), 9 (25%) and 2 (2%) of the isolates derived from humans, companion animals and livestock, respectively. Notably, distinct host associated genotypic resistomes were observed. The Conclusion: We found a phylogenetic delineation of SD strains in line with host adapted populations and niche specialization. Direct transmission of strains or genetic elements carrying resistance genes between SD from different ecological niches appears to be rare in our geographical region.

Indexed as

animalantibiotic resistancehorizontal genetic transferhumanNorwayOne HealthStreptococcus dysgalactiaewhole genomic sequencing

Identifiers

PMID39193432
PMCPMC11348040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.